A Case of Blastic NK-cell Lymphoma

Korean Journal of Dermatology

Volumn 41, Issue 10, 2003, Pages 1381-1384

  Li, Kapsok ^c   Cho, Kwang Hyun ^c   Kim, Chul Woo ^a   Kim, You Chan ^b  

^a Seoul National University College of Medicine   (South Korea)

^b Dankook University College of Medicine   (South Korea)

^c NONE

Author keywords

Blastic NK cell lymphoma; CD56

Indexed keywords

CD20 ANTIGEN; CD3 ANTIGEN; CD56 ANTIGEN; CD79A ANTIGEN; MESSENGER RNA;

ADOLESCENT; ARTICLE; BLASTIC NATURAL KILLER CELL LYMPHOMA; CASE REPORT; CLINICAL FEATURE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MICROSCOPY; NATURAL KILLER CELL; SKIN LYMPHOMA;

EID: 0242494104     PISSN: 04944739     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Child FJ, Mitchell TJ, Whittacker SJ, Calonje E, Spittle M, Crocker J, et al. Blastic natural killer(NK)-cell and extranodal NK-like T-cell lymphoma presenting in the skin: a report of six cases from the UK. Br J Dermatol 2003; 148: 507-15.
2. Santucci M, Pimpinelli N, Massi D, Kadin ME, Meijer CJLM, Mueller-Hermelink HK, et al. Cytotoxic/Natural killer cell cutaneous lymphoma: report of the EORTC cutaneous lymphoma task force workshop. Cancer 2003; 97: 610-27.
3. Chan JKC, Sin VC, Wong KF, Ng CS, Tsang WYW, Chan CH, et al. Non-nasal lymphoma expressing the natural killer cell marker CD56: a clinicopathological study of 49 cases of an uncommon aggressive neoplasm. Blood 1997; 89: 4501-13.
4. DiGiuseppe JA, Louie DC, Williams JE, Miller DT, Griffin CA, Mann RB, et al. Blastic natural killer cell leukemia/lymphoma: a clinicopathological study. Am J Surg Pathol 1997; 21: 1223-30.
5. Slater DN. The new World Health Organization classification of haematopoietic and lymphoid tumours: a dermatopathological perspective. Br J Dermatol 2002; 147: 633-39.
6. Rakozy CK, Mohamed AN, Vo TD, Khatib G, Long PM, Eiler D, et al. CD56+/CD4+ lymphomas and leukemias are morphologically, immunophenotypically, cytogenetically and clinically diverse. Am J Clin Pathol 2001; 116: 168-76.
7. Slater DN. New CD56 positive and cytotoxic T-cell cutaneous lymphomas from the World Health Organisation. Br J Dermatol 2003; 148: 385-87.
8. Natkunam Y, Smoller BR, Zehnder JL, Dorfman R, Wamke RA. Aggressive cutaneous NK and NK-like T-cell lymphomas: clinicopathologic, immunohistochemical, and molecular analyses of 12 cases. Am J Surg Pathol 1999; 23: 571-81.
9. Chang SE, Jee MS, Kim KJ, Choi JH, Sung KJ, Moon KC, et al. Relative frequency of the different types of cutaneous T cell and natural killer cell lymphomas in Korea based on the proposed WHO classification and the EORTC classification. J Dermatol 2003; 30: 42-47.
10. Ko YH, Kim SH, Ree HJ. Blastic NK-cell lymphoma expressing terminal deoxynucleotidyl transferase with Homer-Wright type pseudorosettes formation. Histopathology 1998; 33: 547-53.
11. Hoque SR, Child FJ, Whittaker SJ, Ferreira S, Orchard G, Jenner K, et al. Subcutaneous panniculitis-like T-cell lymphoma: a clinicopathological, immunophenotypic and molecular analysis of six patients. Br J Dermatol 2003; 148: 516-25.
12. Suzuki R, Nakamura S. Malignancies of natural killer (NK) cell precursor: myeloid/NK cell precursor acute leukemia and blastic NK cell lymphoma/leukemia. Leuk Res 1999; 23: 615-24.
13. Chang SE, Choi HJ, Huh J, Choi JH, Sung KJ, Moon KC, et al, A case of primary cutaneous CD56+, TdT+, CD4+, blastic NK-cell lymphoma in a 19-year-old woman. Am J Dermatopathol 2002; 24: 72-75.